OraSure Technologies (OSUR) Competitors

OraSure Technologies logo
$3.59 +0.08 (+2.28%)
Closing price 04:00 PM Eastern
Extended Trading
$3.58 0.00 (-0.14%)
As of 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

OSUR vs. QDEL, CERS, EMBC, SMTI, and ACU

Should you buy OraSure Technologies stock or one of its competitors? OraSure Technologies's main competitors and comparable companies include QuidelOrtho (QDEL), Cerus (CERS), Embecta (EMBC), Sanara MedTech (SMTI), and Acme United (ACU). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare supplies" industry.

How does OraSure Technologies compare to QuidelOrtho?

OraSure Technologies (NASDAQ:OSUR) and QuidelOrtho (NASDAQ:QDEL) are both small-cap healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their risk, analyst recommendations, valuation, media sentiment, institutional ownership, earnings, profitability and dividends.

In the previous week, QuidelOrtho had 6 more articles in the media than OraSure Technologies. MarketBeat recorded 8 mentions for QuidelOrtho and 2 mentions for OraSure Technologies. QuidelOrtho's average media sentiment score of 0.57 beat OraSure Technologies' score of 0.51 indicating that QuidelOrtho is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
OraSure Technologies
0 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
QuidelOrtho
1 Very Positive mention(s)
1 Positive mention(s)
5 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

93.5% of OraSure Technologies shares are held by institutional investors. Comparatively, 99.0% of QuidelOrtho shares are held by institutional investors. 4.7% of OraSure Technologies shares are held by insiders. Comparatively, 1.1% of QuidelOrtho shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

QuidelOrtho has a net margin of -14.24% compared to OraSure Technologies' net margin of -41.73%. QuidelOrtho's return on equity of 3.22% beat OraSure Technologies' return on equity.

Company Net Margins Return on Equity Return on Assets
OraSure Technologies-41.73% -19.81% -16.98%
QuidelOrtho -14.24%3.22%1.03%

OraSure Technologies has a beta of 1.08, suggesting that its share price is 8% more volatile than the broader market. Comparatively, QuidelOrtho has a beta of 0.77, suggesting that its share price is 23% less volatile than the broader market.

QuidelOrtho has a consensus price target of $13.63, suggesting a potential upside of 38.04%. Given QuidelOrtho's higher probable upside, analysts plainly believe QuidelOrtho is more favorable than OraSure Technologies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
OraSure Technologies
1 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
1 Strong Buy rating(s)
2.33
QuidelOrtho
2 Sell rating(s)
4 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.67

OraSure Technologies has higher earnings, but lower revenue than QuidelOrtho. OraSure Technologies is trading at a lower price-to-earnings ratio than QuidelOrtho, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
OraSure Technologies$115.02M2.11-$68.73M-$0.69N/A
QuidelOrtho$2.73B0.25-$1.13B-$5.41N/A

Summary

QuidelOrtho beats OraSure Technologies on 9 of the 16 factors compared between the two stocks.

How does OraSure Technologies compare to Cerus?

OraSure Technologies (NASDAQ:OSUR) and Cerus (NASDAQ:CERS) are both small-cap healthcare companies, but which is the better business? We will compare the two companies based on the strength of their dividends, analyst recommendations, risk, media sentiment, profitability, institutional ownership, valuation and earnings.

Cerus has higher revenue and earnings than OraSure Technologies. Cerus is trading at a lower price-to-earnings ratio than OraSure Technologies, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
OraSure Technologies$115.02M2.11-$68.73M-$0.69N/A
Cerus$206.13M1.86-$15.63M-$0.03N/A

Cerus has a net margin of -3.23% compared to OraSure Technologies' net margin of -41.73%. Cerus' return on equity of -10.44% beat OraSure Technologies' return on equity.

Company Net Margins Return on Equity Return on Assets
OraSure Technologies-41.73% -19.81% -16.98%
Cerus -3.23%-10.44%-3.42%

93.5% of OraSure Technologies shares are owned by institutional investors. Comparatively, 78.4% of Cerus shares are owned by institutional investors. 4.7% of OraSure Technologies shares are owned by company insiders. Comparatively, 5.3% of Cerus shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Cerus has a consensus target price of $5.25, suggesting a potential upside of 176.32%. Given Cerus' stronger consensus rating and higher possible upside, analysts clearly believe Cerus is more favorable than OraSure Technologies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
OraSure Technologies
1 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
1 Strong Buy rating(s)
2.33
Cerus
1 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.40

In the previous week, OraSure Technologies had 1 more articles in the media than Cerus. MarketBeat recorded 2 mentions for OraSure Technologies and 1 mentions for Cerus. Cerus' average media sentiment score of 0.91 beat OraSure Technologies' score of 0.51 indicating that Cerus is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
OraSure Technologies
0 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Cerus
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

OraSure Technologies has a beta of 1.08, suggesting that its share price is 8% more volatile than the broader market. Comparatively, Cerus has a beta of 1.84, suggesting that its share price is 84% more volatile than the broader market.

Summary

Cerus beats OraSure Technologies on 12 of the 17 factors compared between the two stocks.

How does OraSure Technologies compare to Embecta?

Embecta (NASDAQ:EMBC) and OraSure Technologies (NASDAQ:OSUR) are both small-cap healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their institutional ownership, valuation, media sentiment, analyst recommendations, profitability, risk, dividends and earnings.

Embecta has a beta of 0.81, meaning that its stock price is 19% less volatile than the broader market. Comparatively, OraSure Technologies has a beta of 1.08, meaning that its stock price is 8% more volatile than the broader market.

In the previous week, OraSure Technologies had 1 more articles in the media than Embecta. MarketBeat recorded 2 mentions for OraSure Technologies and 1 mentions for Embecta. Embecta's average media sentiment score of 0.89 beat OraSure Technologies' score of 0.51 indicating that Embecta is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Embecta
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
OraSure Technologies
0 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

93.8% of Embecta shares are owned by institutional investors. Comparatively, 93.5% of OraSure Technologies shares are owned by institutional investors. 1.3% of Embecta shares are owned by company insiders. Comparatively, 4.7% of OraSure Technologies shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Embecta has a net margin of 8.59% compared to OraSure Technologies' net margin of -41.73%. Embecta's return on equity of -19.25% beat OraSure Technologies' return on equity.

Company Net Margins Return on Equity Return on Assets
Embecta8.59% -19.25% 10.82%
OraSure Technologies -41.73%-19.81%-16.98%

Embecta presently has a consensus price target of $11.00, indicating a potential upside of 78.86%. Given Embecta's higher probable upside, research analysts clearly believe Embecta is more favorable than OraSure Technologies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Embecta
1 Sell rating(s)
4 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.80
OraSure Technologies
1 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
1 Strong Buy rating(s)
2.33

Embecta has higher revenue and earnings than OraSure Technologies. OraSure Technologies is trading at a lower price-to-earnings ratio than Embecta, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Embecta$1.08B0.32$95.40M$1.484.16
OraSure Technologies$115.02M2.11-$68.73M-$0.69N/A

Summary

Embecta beats OraSure Technologies on 10 of the 16 factors compared between the two stocks.

How does OraSure Technologies compare to Sanara MedTech?

OraSure Technologies (NASDAQ:OSUR) and Sanara MedTech (NASDAQ:SMTI) are both small-cap healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, media sentiment, valuation, dividends, risk, institutional ownership, analyst recommendations and profitability.

Sanara MedTech has a consensus price target of $35.00, suggesting a potential upside of 6.94%. Given Sanara MedTech's higher possible upside, analysts plainly believe Sanara MedTech is more favorable than OraSure Technologies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
OraSure Technologies
1 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
1 Strong Buy rating(s)
2.33
Sanara MedTech
1 Sell rating(s)
4 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.80

93.5% of OraSure Technologies shares are held by institutional investors. Comparatively, 8.1% of Sanara MedTech shares are held by institutional investors. 4.7% of OraSure Technologies shares are held by insiders. Comparatively, 42.0% of Sanara MedTech shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

In the previous week, Sanara MedTech had 1 more articles in the media than OraSure Technologies. MarketBeat recorded 3 mentions for Sanara MedTech and 2 mentions for OraSure Technologies. OraSure Technologies' average media sentiment score of 0.51 beat Sanara MedTech's score of 0.16 indicating that OraSure Technologies is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
OraSure Technologies
0 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Sanara MedTech
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Sanara MedTech has lower revenue, but higher earnings than OraSure Technologies. Sanara MedTech is trading at a lower price-to-earnings ratio than OraSure Technologies, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
OraSure Technologies$115.02M2.11-$68.73M-$0.69N/A
Sanara MedTech$103.12M2.91-$37.56M-$0.35N/A

OraSure Technologies has a beta of 1.08, meaning that its stock price is 8% more volatile than the broader market. Comparatively, Sanara MedTech has a beta of 1.23, meaning that its stock price is 23% more volatile than the broader market.

Sanara MedTech has a net margin of -2.69% compared to OraSure Technologies' net margin of -41.73%. Sanara MedTech's return on equity of 31.65% beat OraSure Technologies' return on equity.

Company Net Margins Return on Equity Return on Assets
OraSure Technologies-41.73% -19.81% -16.98%
Sanara MedTech -2.69%31.65%3.19%

Summary

Sanara MedTech beats OraSure Technologies on 11 of the 16 factors compared between the two stocks.

How does OraSure Technologies compare to Acme United?

Acme United (NYSE:ACU) and OraSure Technologies (NASDAQ:OSUR) are both small-cap healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, valuation, profitability, analyst recommendations, institutional ownership, risk, media sentiment and dividends.

62.1% of Acme United shares are held by institutional investors. Comparatively, 93.5% of OraSure Technologies shares are held by institutional investors. 29.5% of Acme United shares are held by insiders. Comparatively, 4.7% of OraSure Technologies shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

In the previous week, OraSure Technologies had 1 more articles in the media than Acme United. MarketBeat recorded 2 mentions for OraSure Technologies and 1 mentions for Acme United. OraSure Technologies' average media sentiment score of 0.51 beat Acme United's score of 0.19 indicating that OraSure Technologies is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Acme United
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
OraSure Technologies
0 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Acme United has higher revenue and earnings than OraSure Technologies. OraSure Technologies is trading at a lower price-to-earnings ratio than Acme United, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Acme United$220.55M1.20$17.79M$2.7224.62
OraSure Technologies$115.02M2.11-$68.73M-$0.69N/A

Acme United has a net margin of 10.25% compared to OraSure Technologies' net margin of -41.73%. Acme United's return on equity of 9.70% beat OraSure Technologies' return on equity.

Company Net Margins Return on Equity Return on Assets
Acme United10.25% 9.70% 6.10%
OraSure Technologies -41.73%-19.81%-16.98%

Acme United has a beta of 0.35, suggesting that its stock price is 65% less volatile than the broader market. Comparatively, OraSure Technologies has a beta of 1.08, suggesting that its stock price is 8% more volatile than the broader market.

Acme United currently has a consensus price target of $70.00, indicating a potential upside of 4.54%. Given Acme United's higher probable upside, research analysts plainly believe Acme United is more favorable than OraSure Technologies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Acme United
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
OraSure Technologies
1 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
1 Strong Buy rating(s)
2.33

Summary

Acme United beats OraSure Technologies on 9 of the 16 factors compared between the two stocks.

Get OraSure Technologies News Delivered to You Automatically

Sign up to receive the latest news and ratings for OSUR and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding OSUR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

OSUR vs. The Competition

MetricOraSure TechnologiesHealthcare Equipment & Supplies IndustryHealthcare SectorNASDAQ Exchange
Market Cap$242.36M$5.92B$7.60B$11.72B
Dividend YieldN/A1.68%2.47%4.48%
P/E RatioN/A38.8433.5830.13
Price / Sales2.165.688.275.60
Price / CashN/A23.6221.0121.90
Price / Book0.814.214.443.72
Net Income-$68.73M$143.14M$3.50B$393.88M
7 Day Performance0.84%-5.62%-6.53%-6.07%
1 Month Performance-0.55%-3.77%-4.93%-7.38%
1 Year Performance69.34%-0.16%-1.73%-7.48%

OraSure Technologies Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
OSUR
OraSure Technologies
1.7078 of 5 stars
$3.59
+2.3%
N/A+56.0%$242.36M$115.02MN/A500
QDEL
QuidelOrtho
3.7146 of 5 stars
$11.80
-2.4%
$13.63
+15.5%
-53.2%$804.67M$2.73BN/A6,500
CERS
Cerus
2.3173 of 5 stars
$2.01
-3.1%
$5.25
+161.8%
+24.2%$404.91M$206.13MN/A345
EMBC
Embecta
2.4359 of 5 stars
$6.34
-1.2%
$11.00
+73.6%
-57.0%$358.37M$1.08B4.271,850
SMTI
Sanara MedTech
0.5483 of 5 stars
$31.67
-1.4%
$35.00
+10.5%
+55.3%$291.00M$103.12MN/A108

Related Companies and Tools


This page (NASDAQ:OSUR) was last updated on 11/18/2026 by MarketBeat.com Staff.
From Our Partners